The rate of hepatitis C virus infection initiation in vitro is directly related to particle density

Virology

Volumn 407, Issue 1, 2010, Pages 110-119

  Sabahi, Ali ^a   Marsh, Katherine A ^b   Dahari, Harel ^b   Corcoran, Peter ^b   Lamora, Jennifer M ^b   Yu, Xuemei ^b   Garry, Robert F ^a   Uprichard, Susan L ^b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Density; Entry; Hepatitis C virus; Infection initiation

Indexed keywords

ARTICLE; CELL CULTURE; CELL DENSITY; CONTROLLED STUDY; EXTRACELLULAR SPACE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION RATE; NONHUMAN; PRIORITY JOURNAL; VIRION; VIROGENESIS; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PARTICLE; VIRUS TYPING; CELL LINE; CHEMISTRY; CULTURE MEDIUM; DENSITY GRADIENT CENTRIFUGATION; GROWTH, DEVELOPMENT AND AGING; HEPACIVIRUS; LIVER CELL; PHYSIOLOGY; VIROLOGY; VIRUS LOAD;

CELL LINE; CENTRIFUGATION, DENSITY GRADIENT; CULTURE MEDIA; HEPACIVIRUS; HEPATOCYTES; HUMANS; VIRAL LOAD; VIRUS INTERNALIZATION;

HEPATITIS C VIRUS;

CULTURE MEDIUM;

EID: 77956938306     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.07.026     Document Type: Article

References (75)

1. Agnello V., Abel G., Elfahal M., Knight G.B., Zhang Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(22):12766-12771.
2. Aizaki H., Morikawa K., Fukasawa M., Hara H., Inoue Y., Tani H., Saito K., Nishijima M., Hanada K., Matsuura Y., Lai M.M., Miyamura T., Wakita T., Suzuki T. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J. Virol. 2008, 82(12):5715-5724.
3. Andre P., Komurian-Pradel F., Deforges S., Perret M., Berland J.L., Sodoyer M., Pol S., Brechot C., Paranhos-Baccala G., Lotteau V. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 2002, 76(14):6919-6928.
4. Andreo U., Maillard P., Kalinina O., Walic M., Meurs E., Martinot M., Marcellin P., Budkowska A. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. Cell. Microbiol. 2007, 9(10):2445-2456.
5. Bagai S., Lamb R.A. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J. Virol. 1995, 69(11):6712-6719.
6. Barth H., Schafer C., Adah M.I., Zhang F., Linhardt R.J., Toyoda H., Kinoshita-Toyoda A., Toida T., Van Kuppevelt T.H., Depla E., Von Weizsacker F., Blum H.E., Baumert T.F. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 2003, 278(42):41003-41012.
7. Barth H., Schnober E.K., Zhang F., Linhardt R.J., Depla E., Boson B., Cosset F.L., Patel A.H., Blum H.E., Baumert T.F. Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J. Virol. 2006, 80(21):10579-10590.
8. Bartosch B., Dubuisson J., Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 2003, 197(5):633-642.
9. Bartosch B., Vitelli A., Granier C., Goujon C., Dubuisson J., Pascale S., Scarselli E., Cortese R., Nicosia A., Cosset F.L. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 2003, 278(43):41624-41630.
10. Benedicto I., Molina-Jimenez F., Bartosch B., Cosset F.L., Lavillette D., Prieto J., Moreno-Otero R., Valenzuela-Fernandez A., Aldabe R., Lopez-Cabrera M., Majano P.L. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection. J. Virol. 2009, 83(16):8012-8020.
11. Blanchard E., Belouzard S., Goueslain L., Wakita T., Dubuisson J., Wychowski C., Rouille Y. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J. Virol. 2006, 80(14):6964-6972.
12. Blight K.J., Kolykhalov A.A., Rice C.M. Efficient initiation of HCV RNA replication in cell culture. Science 2000, 290(5498):1972-1975.
13. Blight K.J., McKeating J.A., Marcotrigiano J., Rice C.M. Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture. J. Virol. 2003, 77(5):3181-3190.
14. Bradley D., McCaustland K., Krawczynski K., Spelbring J., Humphrey C., Cook E.H. Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. J. Med. Virol. 1991, 34(3):206-208.
15. Burlone M.E., Budkowska A. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J. Gen. Virol. 2009, 90(Pt 5):1055-1070.
16. Burtonboy G., Delferriere N., Mousset B., Heusterspreute M. Isolation of a C-type retrovirus from an HIV infected cell line. Arch. Virol. 1993, 130(3-4):289-300.
17. Choi S., Sainz B., Corcoran P., Uprichard S.L., Jeong H. Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells. Xenobiotica 2009, 39(3):205-217.
18. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162(1):156-159.
19. Choo Q.-L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244:359-362.
20. Cooper P.D. The plaque assay of animal viruses. Methods in Virology 1967, vol. III:243-311. Academic Press, New York and London.
21. Culp T.D., Christensen N.D. Kinetics of in vitro adsorption and entry of papillomavirus virions. Virology 2004, 319(1):152-161.
22. Dreux M., Pietschmann T., Granier C., Voisset C., Ricard-Blum S., Mangeot P.E., Keck Z., Foung S., Vu-Dac N., Dubuisson J., Bartenschlager R., Lavillette D., Cosset F.L. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. J. Biol. Chem. 2006, 281(27):18285-18295.
23. Evans M.J., von Hahn T., Tscherne D.M., Syder A.J., Panis M., Wolk B., Hatziioannou T., McKeating J.A., Bieniasz P.D., Rice C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007, 446(7137):801-805.
24. Farquhar M.J., McKeating J.A. Primary hepatocytes as targets for hepatitis C virus replication. J. Viral Hepat. 2008, 15(12):849-854.
25. Gastaminza P., Kapadia S.B., Chisari F.V. Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J. Virol. 2006, 80(22):11074-11081.
26. Gastaminza P., Cheng G., Wieland S., Zhong J., Liao W., Chisari F.V. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J. Virol. 2008, 82(5):2120-2129.
27. Grove J., Huby T., Stamataki Z., Vanwolleghem T., Meuleman P., Farquhar M., Schwarz A., Moreau M., Owen J.S., Leroux-Roels G., Balfe P., McKeating J.A. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J. Virol. 2007, 81(7):3162-3169.
28. Grove J., Nielsen S., Zhong J., Bassendine M.F., Drummer H.E., Balfe P., McKeating J.A. Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies. J. Virol. 2008, 82(24):12020-12029.
29. Haid S., Pietschmann T., Pecheur E.I. Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles. J. Biol. Chem. 2009, 284(26):17657-17667.
30. Hirano N., Hino S., Fujiwara K. Physico-chemical properties of mouse hepatitis virus (MHV-2) grown on DBT cell culture. Microbiol. Immunol. 1978, 22(7):377-390.
31. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C.M., McKeating J.A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(12):7271-7276.
32. Huang Y., Yang Z.Y., Kong W.P., Nabel G.J. Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production. J. Virol. 2004, 78(22):12557-12565.
33. Hung S.L., Lee P.L., Chen H.W., Chen L.K., Kao C.L., King C.C. Analysis of the steps involved in dengue virus entry into host cells. Virology 1999, 257(1):156-167.
34. Ikeda M., Yi M., Li K., Lemon S.M. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J. Virol. 2002, 76(6):2997-3006.
35. Kapadia S.B., Barth H., Baumert T., McKeating J.A., Chisari F.V. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 2007, 81(1):374-383.
36. Kartenbeck J., Stukenbrok H., Helenius A. Endocytosis of simian virus 40 into the endoplasmic reticulum. J. Cell Biol. 1989, 109(6 Pt 1):2721-2729.
37. Kato T., Furusaka A., Miyamoto M., Date T., Yasui K., Hiramoto J., Nagayama K., Tanaka T., Wakita T. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J. Med. Virol. 2001, 64(3):334-339.
38. Kato T., Date T., Miyamoto M., Furusaka A., Tokushige K., Mizokami M., Wakita T. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 2003, 125(6):1808-1817.
39. Kim M., Ha Y., Park H.J. Structural requirements for assembly and homotypic interactions of the hepatitis C virus core protein. Virus Res. 2006, 122(1-2):137-143.
40. Kokorev V.S., Podoplekin V.D., Pereverzev V.D., Fedotova T.T. Buoyant density of some togaviruses in sucrose density gradient and capacity of their haemagglutinin fractions to interact with antibody. Acta Virol. 1976, 20(5):353-360.
41. Koutsoudakis G., Kaul A., Steinmann E., Kallis S., Lohmann V., Pietschmann T., Bartenschlager R. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 2006, 80(11):5308-5320.
42. Lavillette D., Bartosch B., Nourrisson D., Verney G., Cosset F.L., Penin F., Pecheur E.I. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. J. Biol. Chem. 2006, 281(7):3909-3917.
43. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 2005, 309(5734):623-626.
44. Lindenbach B.D., Meuleman P., Ploss A., Vanwolleghem T., Syder A.J., McKeating J.A., Lanford R.E., Feinstone S.M., Major M.E., Leroux-Roels G., Rice C.M. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(10):3805-3809.
45. Liu S., Yang W., Shen L., Turner J.R., Coyne C.B., Wang T. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 2009, 83(4):2011-2014.
46. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285(5424):110-113.
47. Macnaughton M.R., Davies H.A. Two particle types of avian infectious bronchitis virus. J. Gen. Virol. 1980, 47(2):365-372.
48. Meanwell N.A. Hepatitis C virus entry: an intriguing challenge for drug discovery. Curr. Opin. Investig. Drugs 2006, 7(8):727-732.
49. Meertens L., Bertaux C., Dragic T. Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J. Virol. 2006, 80(23):11571-11578.
50. Molina S., Castet V., Fournier-Wirth C., Pichard-Garcia L., Avner R., Harats D., Roitelman J., Barbaras R., Graber P., Ghersa P., Smolarsky M., Funaro A., Malavasi F., Larrey D., Coste J., Fabre J.M., Sa-Cunha A., Maurel P. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J. Hepatol. 2007, 46(3):411-419.
51. Monazahian M., Bohme I., Bonk S., Koch A., Scholz C., Grethe S., Thomssen R. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 1999, 57(3):223-229.
52. Moradpour D., Penin F., Rice C.M. Replication of hepatitis C virus. Nat. Rev. Microbiol. 2007, 5(6):453-463.
53. Nielsen S.U., Bassendine M.F., Burt A.D., Martin C., Pumeechockchai W., Toms G.L. Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J. Virol. 2006, 80(5):2418-2428.
54. Niiyama Y., Igarashi K., Tsukamoto K., Kurokawa T., Sugino Y. Biochemical studies on bovine adenovirus type 3. I. Purification and properties. J. Virol. 1975, 16(3):621-633.
55. Pietschmann T., Zayas M., Meuleman P., Long G., Appel N., Koutsoudakis G., Kallis S., Leroux-Roels G., Lohmann V., Bartenschlager R. Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations. PLoS Pathog. 2009, 5(6):e1000475.
56. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., Abrignani S. Binding of hepatitis C virus to CD81. Science 1998, 282(5390):938-941.
57. Ploss A., Evans M.J., Gaysinskaya V.A., Panis M., You H., de Jong Y.P., Rice C.M. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009, 457(7231):882-886.
58. Poynard T., Ratziu V., Benhamou Y., Opolon P., Cacoub P., Bedossa P. Natural history of HCV infection. Baillières Best Pract. Res. Clin. Gastroenterol. 2000, 14(2):211-228.
59. Poynard T., Yuen M.F., Ratziu V., Lai C.L. Viral hepatitis C. Lancet 2003, 362(9401):2095-2100.
60. Pumeechockchai W., Bevitt D., Agarwal K., Petropoulou T., Langer B.C., Belohradsky B., Bassendine M.F., Toms G.L. Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: implications for virus clearance by antibody. J. Med. Virol. 2002, 68(3):335-342.
61. Sainz B., Barretto N., Uprichard S.L. Hepatitis C Virus infection in phenotypically distinct Huh7 cell lines. PLoS ONE 2009, 4(8):e6561.
62. Saunier B., Triyatni M., Ulianich L., Maruvada P., Yen P., Kohn L.D. Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J. Virol. 2003, 77(1):546-559.
63. Scarselli E., Ansuini H., Cerino R., Roccasecca R.M., Acali S., Filocamo G., Traboni C., Nicosia A., Cortese R., Vitelli A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002, 21(19):5017-5025.
64. Smith T.J., Brandt W.E., Swanson J.L., McCown J.M., Buescher E.L. Physical and biological properties of dengue-2 virus and associated antigens. J. Virol. 1970, 5(4):524-532.
65. Thomssen R., Bonk S., Propfe C., Heermann K.-H., Kochel H.G., Uy A. Association of hepatitis C virus in human sera with B-lipoprotein. Med. Microbiol. Immunol. 1992, 181:293-300.
66. Thomssen R., Bonk S., Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med. Microbiol. Immunol. (Berl) 1993, 182(6):329-334.
67. Tscherne D.M., Jones C.T., Evans M.J., Lindenbach B.D., McKeating J.A., Rice C.M. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J. Virol. 2006, 80(4):1734-1741.
68. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11(7):791-796.
69. Weiss L., Kekule A.S., Jakubowski U., Burgelt E., Hofschneider P.H. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs. Virology 1996, 216(1):214-218.
70. Wong-Staal F., Yang J.P., Chang J., Troung K., Lee H., Tang H., Rijnbrand R. 15th International Symposium on Hepatitis C Virus & Related Viruses 2008, San Antonio, TX.
71. Wunschmann S., Medh J.D., Klinzmann D., Schmidt W.N., Stapleton J.T. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J. Virol. 2000, 74(21):10055-10062.
72. Yi M., Rodrigo A., Villanueva R.A., Thomas D.L., Wakita T., Lemon S.M. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(7):2310-2315.
73. Zeisel M.B., Koutsoudakis G., Schnober E.K., Haberstroh A., Blum H.E., Cosset F.L., Wakita T., Jaeck D., Doffoel M., Royer C., Soulier E., Schvoerer E., Schuster C., Stoll-Keller F., Bartenschlager R., Pietschmann T., Barth H., Baumert T.F. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 2007, 46(6):1722-1731.
74. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(26):9294-9299.
75. Zhong J., Gastaminza P., Chung J., Stamataki Z., Isogawa M., Cheng G., McKeating J.A., Chisari F.V. Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J. Virol. 2006, 80(22):11082-11093.